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Access and Benefit Sharing of Marine Genetic Resources
from Areas beyond National Jurisdiction: Intellectual
Property-Friend, Not Foe
Eve Heafey*
Abstract
The applicable internalional legal framework for the governance of marine genetic
resources from areas beyond nationaljurisdicion is difficult to sort out- at best, it is unclear
under which regime such resources fall, and at worst, there is no applicable regime. Despite the
ambigui, the bioprospecting of these resources is ongoing and increasingly being undertakenfor
commerdalpurposes. Itfollows that intellectualpropery claims, such as patents on inventions
and copyrights onpublications describing discoveries, are being sought in relation to inventions
andpublications derivingfrom these bioprospecting efforts. As a result, nation states are raising
important questions regarding the protection of knowledge deriving from these resources using
intellectual propery rights and the implicalions of such protection in international law,
including the rights granted by the United Nations Convention on the Law of the Sea, as well
as with regard to access and benefit sharing obligations under the Convention on Biological
Diversiy.
ThisAricle identfies some of the options availabe to nation states to fulfill access and
beneft sharing obligations using the intellectualproperty right system, rather than acting in
spite of it, by briefly discussing the tenets of this system and the possibilities it unleashes.
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I. INTRODUCTION
Marine genetic resources (MGRs) from areas beyond national jurisdiction
are currently the focus of great interest in the fields of both science and
international law. Scientists are attracted to the immense potential of this mostly
untapped resource, notably for applications in the medical and pharmaceutical
industries. Not surprisingly, the potential of these resources has also attracted
much attention from the international and legal spheres with respect to the
intellectual property protections that can be afforded to discoveries and
inventions stemming from MGRs in areas beyond national jurisdiction.
The value of these MGRs lies in their genetic material, particularly in the
genetic variability of the material in question. Those variations codify the
particular adaptations of every living organism. The genetic material, which
makes them different, is also the genetic material that can be most useful.
A momentous example of the value of deep-sea genetic resources is the
discovery of the green fluorescent protein (GFP), from the biolurinescent
Aequorea victoria jellyfish.1 GFP was developed into what many call the
"microscope of the twenty-first century."2 Indeed, GFP is essentially used as a
biological highlighter, oftentimes to literally light up a particular protein
produced by a specific GFP-tagged gene. GFP can illuminate growing cancer
tumors, reveal the development of Alzheimer's disease in the brain, and show
how HIV travels from infected to noninfected cells. Osamu Shimomura, Martin
Chalfie and Roger Y. Tsien received the Nobel Prize in Chemistry for the
discovery and development of GFP.4
It is a longstanding scientific tradition to draw inspiration from nature. The
genetic material of the living resources of the deep sea is particularly interesting
because of their adaptability to extreme environments. It is also important to
note that the abundant biodiversity of the deep sea may in fact rival tropical
forests in species diversity, and it is believed that proteins having useful
applications are more likely to be found in marine microbial life than terrestrial
organisms.' MGRs are therefore in the spotlight and may hold the key to many
useful and beneficial discoveries. As an example, more than 150 natural products
I Roger Y. Tsien, The Green .Fluorescent Protein, 67 ANN. REV. BIOCiHEMISrRY 509 (1998).
2 See, for example, Green Fluorescent Protein: A Molecular Microscope, http://www.photobiology.info/
Zimmer.html (last visited Nov. 13, 2013).
3 MARC ZIMMER, GLOWING GENES (Prometheus Books 2005).
4 The Nobel Prize in Chemistg 2008, NOBELPRIZE.ORG, http://www.nobelprize.org/nobel-prizes/
chernistry/laureates/2008/popular-chemistryprize2008.pdf (last visited Nov. 3, 2013).
G. Kristin Rosendal, Balancing Access and Benefit Sharing and Legal Protection of Innovations from
Bioprospecting: Impacts on Conservation ofBiodiversioT, 15 J. ENV'T & Di :v. 428, 431 (2006).
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with promising levels of anti-HIV activity have been isolated from manine
organisms.6
Hence, marine research is increasingly undertaken for a commercial
purpose and is now commonly referred to as marine bioprospecting, although it
is still unclear whether all bioprospecting is a commercial endeavor.
Bioprospecting involves a series of phases, starting from the initial discovery of a
marine genetic resource. A sample is then recovered from the environment.
These steps are usually part of a collaboration between industry and public
researchers, such as scientists from institutions like public oceanographic
research centers. The recovered sample is then brought back to a laboratory
where the phenotype and genotype are identified. The genetic material of
interest is isolated and studied to determine its possible applications.7 This labor-
intensive process may lead to intellectual property (IP) claims, including patents
on inventions and copyrights on publications describing discoveries.'
Many states are, however, expressing their concerns regarding IP claims on
discoveries that stem from MGRs found in areas beyond national jurisdiction.
These states generally fear that granting intellectual property rights (IPRs) to
these discoveries may result in less knowledge available to the public. On the
other hand, some states insist that restricting the intellectual property regime
with regards to MGRs will decrease incentives for investments, thereby stifling
research and development in this field and depriving the public of valuable
advancements.9
This Article aims to reflect on these concerns in light of international law
and current policy discussions. Firstly, the relevant legal instruments that govern
marine areas beyond national jurisdiction and the genetic resources contained
therein will be described. It should be noted that marine genetic resources found
within areas of national jurisdiction are beyond the scope of this work.
Following this description, this Article will explore the international legal
framework of IP, including the possibilities arising from the IP system to
6 David Leary, et al., Marine Genetic Resources:A Review of Scientific and Commercial Interest, 33 MARINE
Po.'y 183, 186 (2009).
7 Charlotte Salpin & Valentina Germani, Patenting of Research Results Related to Genetic Resources from
Areas Beyond National Jurisdiction: The Crossroads of the Law of the Sea and Intellectual Propert Law, 16
REV. EUR. COMMUNITY & INT'L ENVTL. L. 12, 16 (2007) [hereinafter "Salpin'".
8 As an example, an initial patent on GFP uses was issued to Martin Lee Chalfie et al. in 1976 (U.S.
Patent No. 5491084) and was followed by over 500 patents in the U.S. alone covering GFP in
some form in the patent claims, according to the USPTO. Regarding copyrights, the number of
peer-reviewed scholarly articles published on GFP worldwide is on the order of 2000 publications
per year, according to SciFinder.
9 C.f. Letter dated 16 March 2010 from the Co-Chairpersons of the Ad Hoc Open-ended Informal
Working Group to the President of the General Assembly (65th Sess.) 75, U.N. Doc. A/65/68
(Mar. 16, 2010) [hereinafter "A/65/68"].
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balance global interests while maintaining the incentives for marine
bioprospecting in areas beyond national jurisdiction."
II. THE ESTABLISHED PAST"
This section will describe the existent legal framework that is relevant to
marine genetic resources found in areas beyond national jurisdiction.
A. The Law of the Sea and Biodiversity
Although the United Nations Convention on the Law of the Sea
(UNCLOS) does not specifically refer to biodiversity conservation or utilization
of genetic resources, the convention is highly relevant to our discussion. Indeed,
UNCLOS is often referred to as the constitution for the oceans because it
regulates all activities carried out in the seas and oceans. 2 Furthermore,
UNCLOS refers to the responsibility of conservation of the living resources 13
and recognizes the desirability of the equitable and efficient utilization of marine
resources. 14
In areas beyond national jurisdiction, which are the focus of this work, the
seabed (the Area)" and the water column are governed by two different legal
regimes. 6 The MGRs of interest in this work can be found in both
environments: within the marine seabed of areas beyond national jurisdiction as
well as in the water column above it.
1. The Area: common heritage of mankind (Part XI).
UNCLOS Part XI regulates the Area (the seabed and its subsoil beyond
areas of national jurisdiction) and states that it and its mineral resources are the
10 Although bioprospecting may have a significant impact on the environment, such issues will only
be discussed in the context of the potential role of intellectual property in addressing them.
11 For a recent review of the international law of the sea, see DONALD R. ROTIIWELI & TIM
STEPHENS, TILE INTERNATIONAL LAW OF THE SEA (Oxford, Hart Publishing 2010). See also
Charlotte Salpin & Valentina Germani, Marine Protected Areas Beyond Areas of National Jurisdiction:
What's Mine is Mine and What You Think is Yours is also Mine, 19 REv. EUR. COMMUNITY& INT'.
ENVT. L. 174 (2010).
12 Addendum Report of the Secretary General on Oceans and the Law of the Sea to the General
Assembly (60th Sess.) 227, U.N. Doc. A/60/63/Add.1 (Jul. 15, 2005) [hereinafter
"A/60/63/Add.1'.
13 United Nations Convention on the Law of the Sea, Arts. 116-120, Dec. 10, 1982, 1833 U.N.T.S. 3
[hereinafter "UNCLOS"]. See also id., art. 192 (outlining the general obligation to protect and
preserve the marine environment).
14 Id., Preamble.
15 Id., art. 1 (1) (1).
16 Salpin, supra note 7, at 12.
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common heritage of mankind.1 In particular, Articles 136 and 137 of UNCLOS
establish that no state shall claim sovereign rights over these resources and that
activities in the Area must be carried out for the benefit of mankind. For the
purposes of UNCLOS, these activities are defined as exploration for, and
exploitation of, the mineral resources. 8 The International Seabed Authority
(ISA) is the organization through which states organize and control activities in
the Area and that provides for the equitable sharing of financial and other
economic benefits derived from these activities.'9
2. Water column: freedom of the high seas (Part VII).
UNCLOS also establishes in Articles 87 and 89 that the high seas (the
water column beyond areas of national jurisdiction) are open to all states and
governed by the principles of freedom of the high seas. This regime includes the
freedom of navigation, the freedom of overflight, and the freedom of fishing
20
but is restricted, as these freedoms must be exercised with due regard for other
states' interests in their exercise of these same freedoms .21 States also possess the
freedom of scientific research, which will be discussed in the following section.
3. Marine scientific research.
Part XlIi of UNCLOS, which establishes that states have the right to
conduct marine scientific research, generally governs such research in areas
beyond national jurisdiction, but this right is again subject to the rights and
duties of other states. 2
UNCLOS also prescribes that marine scientific research shall only be
conducted for peaceful purposes and in conformity with regulations adopted for
the protection and preservation of the marine environment.' UNCLOS
establishes a balance with respect to the exercise of this right to research, stating
that research projects cannot unjustifiably interfere with other legitimate uses of
the sea but that research shall be respected in the course of such other uses.24
UNCLOS establishes that all marine scientific research "shall not
constitute the legal basis for any claim to any part of the marine environment or
17 UNCLOS, supra note 13, arts. 133, 136.
18 Id., art. 1(1)(3).
19 Id., art. 140.
20 Id., art. 87(1).
21 UNCLOS, supra note 13, art. 87(2).
22 Id., art. 238.
23 Id., art. 240(a), (d).
24 Id., art. 240(c).
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its resources. 25 Furthermore, states are required to actively promote the flow of
scientific data and information and the transfer of knowledge resulting from this
research.26
Marine scientific research in the Area, like all activities in the Area, must be
conducted for the benefit of mankind as a whole,27 and states are obligated to
promote international cooperation in marine scientific research and the transfer
of technology, particularly to developing states.28 As noted above, states enjoy
the freedom of scientific research in the water column beyond national
jurisdiction.'
Importantly, no provision of UNCLOS distinguishes between marine
scientific research carried out for commercial purposes and research that does
not have direct commercial applications or potential. 0
4. Convention on Biological Diversity.'
The primary objectives of the Convention on Biological Diversity (CBD)
are "the conservation of biological diversity, the sustainable use of its
components and the fair and equitable sharing of the benefits arising out of the
utilization of genetic resources."31
To achieve the latter objective, the Conference of the Parties to the CBD
adopted the Bonn Guidelines on Access to Genetic Resources and Fair and
Equitable Sharing of the Benefits Arising out of Their Utilization.32 These
25 UNCLOS, supra note 13, art. 241. See also Montserrat Gorina-Ysern, Marine Scientific Research
Activities as the Legal Basisfor Intellectual Propery Claims?, 22 MARINE POL'Y 337 (1998).
26 UNCLOS, supra note 13, art. 244.
27 Id., art. 143(1).
28 Id., art. 144.
29 Id., arts. 87.1(0, 257.
30 Tullio Scovazzi, The Seabed Beyond the Limits of National Jurisdiction: General and Institutional Aspects,
TIlE INTERNATIONAI. LEGAL REGIME OF AREAS BEYOND NATIONAL JURISDICTION: CURRENT
AN) FUTURE DEVEI.OPMENTS 43, 58 (ErikJ. Molenaar & Alex G. Oude Elferink eds., 2010).
31 Convention on Biological Diversity, art. 1, Jun. 5, 1992, 1760 U.N.T.S. 79 [hereinafter "CBD'".
Pursuant to article 22(2) of the CBD, contracting parties are required to implement the
convention with respect to the marine environment consistent with the rights and obligations of
states under the law of the sea.
32 Adopted by the sixth meeting of the Conference of the Parties of the CBD, as part of its Decision
VI/24, found in the Report of the Sixth Meeting of the Conference of the Parties to the
Convention on Biological Diversity, Annex, UNEP/CBD/COP/6/20 (May 27, 2002)
[hereinafter "Bonn Guidelines']. The CBD has thus become the primary global forum addressing
access and benefit sharing (ABS). As a pioneering ABS instrument, the CBD principles have
influenced various other fora, including the Antarctic Treaty System, the Food and Agriculture
Organization, the U.N. General Assembly, the World Health Organization, and the World Trade
Organization with its work on Trade-Related Aspects of Intellectual Property. See Lyle Glowka,
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guidelines are notably meant to assist states in developing and drafting
legislative, administrative, and policy measures on the access to genetic resources
and the sharing of benefits deriving from them.33
The CBD framework was expanded with the adoption of the Protocol on
Access to Genetic Resources and the Fair and Equitable Sharing of Benefits
Arising from Their Utilization (Nagoya Protocol) on October 29, 2010 by the
Conference of the Parties to the CBD' The Nagoya Protocol, which aims to
provide a legal framework for the effective implementation of the third objective
of the CBD, namely fair and equitable sharing of benefits, will enter into force
ninety days after the fiftieth instrument of ratification.3" The Nagoya Protocol
aims to establish more predictable conditions for access to genetic resources and
help ensure benefit sharing when genetic resources leave the contracting party
providing the genetic resources.36 For instance, the Protocol establishes an
Access and Benefit Sharing (ABS) Clearing-House as part of the clearing-house
mechanism of the CBD, which will provide access to information made available
by each party relevant to the implementation of the Protocol."3 The Protocol
also establishes issuance of internationally recognized certificates by the relevant
national authority, which certify that a genetic resource has been obtained,
accessed, and used in accordance with prior consent of the national authority
having jurisdiction over the genetic resource.38 The Nagoya Protocol also
addresses specific transborder cases and other cases where it is not possible to
obtain prior consent from the relevant national authority by setting out a Global
Multilateral Benefit Sharing Mechanism.39 The parties have agreed to further
develop this mechanism according to their needs and as such, it may be an
Genetic Resources, Marine Scientific Research and the International SeabedArea, 8 REv. EUR. COMMUNITY
& INT'L ENVTL. L. 56 (1999) [hereinafter "Glowka'".
33 WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional
Knowledge and Folklore (7th Sess.), Genetic Resources: Draft Intellectual Property Guidelines for Access
and Equitable Benefit-Sharing, 26, WIPO/GRTKF/IC/7/9 (Jul. 30, 2004) [hereinafter
"WIPO/GRTKF/IC/7/9'1.
34 Conference of the Parties to the Convention on Biological Biodiversity, Tenth meeting, Nagoya,
Jap., Oct. 18-29, 2010, Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing
of Benefits Arising from Their Utilization to the Convention on Biological Diversi, U.N. Doc.
UNEP/CBD/COP/DEC/X/1, Annex 1, (Oct. 29, 2010) [hereinafter "Nagoya Protocol"].
35 As of the date of publication of this Article, there were twenty-six ratifications to the Nagoya
Protocol. See Status of Signature, and Ratification, Acceptance, Approval or Accession, CONVENTION OF
BIOLOGICo DIVERSITY, http://www.cbd.int/abs/nagoya-protocol/signatories (last visited Nov.
5,2013).
36 Nagoya Protocol, supra note 34, Introduction.
37 Id., art. 14; CBD, supra note 31, art. 18(3).
38 Nagoya Protocol, supra note 34, art. 17.
39 Id., art. 10.
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interesting approach to monitor in solving the issues surrounding marine genetic
resources from areas beyond national jurisdiction.'
Generally speaking, however, the CBD regime applies to the utilization of
genetic resources that are found within areas ofnalionaljurisdiction. Therefore, CBD
ABS requirements have limited applicability to MGRs in areas beyond national
jurisdiction since they apply only to activities beyond national jurisdiction to the
extent that states regulate the activities of their own nationals.4 Specifically, the
Convention applies to all processes and activities carried out under the national
jurisdiction or control of a Contracting State, whether within the area of its
national jurisdiction or beyond its limits and regardless of where the effects
occur.
42
In areas beyond national jurisdiction, the CBD provides that states must
cooperate directly with each other or through competent international
organizations for the conservation and sustainable use of biological diversity.43
According to G. Kristin Rosendal, the CBD regards equitable sharing as a
prerequisite for achieving the objectives of conservation and sustainable use.'
CBD provisions do not affect the rights and obligations of member states
that arise from other existing international agreements, unless the exercise of
those rights and obligations would cause a serious damage or threat to biological
diversity.4" The CBD also provides that member states must cooperate to ensure
that intellectual property rights are in line with the CBD's objectives, subject to
national and international law.'
B. Intellectual Property Law: Patents and Copyrights
Intellectual property refers to creations of the mind such as inventions,
literary and artistic works, as well as symbols, names, images, and designs used in
commerce.47  IP protections encompass patents, copyrights, trademarks,
industrial designs, and geographical indications. This work will focus on patents
and copyrights because they are the most relevant to marine genetic resources
40 Id., supra note 34, Introduction.
41 United Nations Informal Consultative Process on Oceans and the Law of the Sea (8th mtg.), An
Update on Marine Genetic Resources: Scientific Research, Commercial Uses and a Database on Marine
Bioprospecting, at 32 (Jun. 2007) [hereinafter "An Update on MGRs'1.
42 CBD, supra note 31, art. 4(b).
43 Id., art. 5.
44 Rosendal, supra note 5, at 432.
45 CBD, spra note 31, art. 22.
46 Id., art. 16(5).
47 What is lntellectualPropero?, WORID INTELLECTUAL PROPERTY ORGANIZATION, http://www.wipo.
int/about-ip/en/ (last visited Nov. 5, 2013).
Winter 2014
Heafge
Chicago Journal of International Lair
and associated discoveries, and perhaps the most discussed in this context. All
intellectual property protection is a matter of national jurisdiction, although it is
subject to international agreements entered into by states.
The rationale of the UNCLOS provisions on marine scientific research
actually corresponds well with the objectives of intellectual property protections,
as they are both largely founded on the belief that universality of scientific
knowledge is a foundation for the advancement of mankind.48
1. Purpose and general principles.
Patent and copyrights are the oldest forms of intellectual property
protection and thus the ones with the greatest historical foundations. The
policies underlying patents and copyrights are comparable, as both seek to
increase the store of human knowledge.49 The IP system accomplishes this by
creating incentives for inventors and creators to produce and reveal new
scholarship and inventions, in the form of exclusive rights with respect to these
works for a limited time."° After that time, the work passes into the public
domain."5
The United States Supreme Court has notably equated the public policies
of copyright and patent, stating that the economic philosophy behind patent and
copyright protection is "the conviction that encouragement of individual effort
by personal gain is the best way to advance public welfare through the talents of
authors and inventors in 'Science and useful Arts."'5 2
The promise of an exclusive right encourages the reduction to practice of
an invention, 3 and the disclosure of inventions and creations such that they
become useful to the public. The justification for a limited exclusive right is
48 Salpin, sufpra note 7, at 17.
49 Lasercomb America, Inc. v. Reynolds, 911 F.2d 970, 975-76 (4th Cir. 1990).
50 David W. Opderbeck, A Virtue-Centered Approach to the Biotechnology Commons (Or, the Virtuous
Penguin), 59 ME. L. REV. 316, 317 (2007).
51 See ROGER E. SCHECHTER & JOHN R. THOMAS, INTELLECTUAL PROPERTY-TLE LAW OF
COPYRIGHTS, PATENTS AND TRADEMARKS § 1.2.4 (Thomson West, 2003) (describing the benefit
to the public domain after expiration of patent or copyright) [hereinafter "SCHECIITER"].
52 Mazer v. Stein, 347 U.S. 201,219 (1954). SeegenerallySci-iECIITER, supra note 51, § 1.3.1 (describing
the incentive of IP to create). ROBERT P. MERGES ET AL., INTELLECTUAL PROPERTY IN THE NEW
TECHNOLOGICAL AGE 11 (4th ed., Aspen Law & Business 2006) [hereinafter "MERGES'].
53 SCHECHTER, supranote 51, § 16.3.2.4 (stating that an invention can be reduced to practice in two
ways: (1) constructively, by filing a patent that adequately discloses the invention, in a manner that
enables one skilled in the art to practice the invention without the exercise of inventive facilities;
or (2) by constructing a working physical embodiment of the invention).
Vol 14 No. 2
Marine Genetic Resources
grounded in the premise that had it not been for the inventor's (or creator's)
work and its disclosure, the public would never have benefited from it.'A
These intellectual property rights promote information sharing by
encouraging the creator or inventor to make the work publically known, in
exchange for the benefits of exclusive rights. The protection of intellectual
goods prompts creators and inventors to share their work immediately rather
than keep it secret, by giving them a right of action against imitations and
forgeries. This incentive promotes the dissemination of knowledge. " Indeed, the
public benefits both immediately from the disclosure of the work, and later from
the work's incorporation to the public domain when the term of protection of
the work expires. IP rights also stimulate innovation and encourage technology
transfer, due to the increased confidence in information sharing.
It is important to realize that the IP system does not grant the right to use
these works, only granting the right to exclude others from using them.56 This
distinction is significant in the context of works that are harmful or otherwise
dangerous; patents on biological weapons, for instance, would be allowed but
criminal and other laws would regulate their use. Indeed, the use of patented
works is regulated by legal instruments that are not necessarily related to
intellectual property protections.
2. Rules and minimum standards of IP protection in
international law.
As many developed nations moved towards knowledge-based economies,
IP became the pivot of their global competitiveness.57 These nations thus
became vulnerable to free riding practices and piracy and lobbied for the
inclusion of intellectual property in the framework of the General Agreement on
Tariffs and Trade (GATT), which is meant to promote the reduction of tariff
barriers to the international movement of goods.58 This inclusion occurred in
1994 at the Uruguay Round of GATT negotiations and led to the Trade Related
54 Id., § 1.3.
55 This fundamental purpose of IP is compatible with the UNCLOS principles of enhanced flow of
marine scientific research information. UNCLOS, supra note 13, Art. 244. In general terms, the
interaction of UNCLOS with other international agreements is handled by Art. 311 (stating that
UNCLOS does not alter the rights and obligations of States arising from other agreements, which
are compatible with UNCLOS and do not affect other States' enjoyment of their rights or the
performance of their obligations under UNCLOS).
56 SCHECIIT;R, spra note 51, § 1.2.2.
57 Haochen Sun, Overcoming the Achilles Heel of Copgyright Law, 5 Nw. J. TECH. & INTEiLL. PRoP. 265,
274 (2007).
58 J.H. Reichman, Intellectual Property in InternationalTrade: Opportunities and Risks of a GA I Connection,
22 VAND. J. TRANSNAT'I. L. 747,751-52 (1989).
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Aspects of Intellectual Property (TRIPs) Agreement, 9  which provides
international minimum standards for IP protection.'
TRIPs aims to reduce impediments to international trade and to ensure
that the enforcement of TPRs does not become a barrier to legitimate trade.61
The minimum national protection standards for IP are intended to promote the
free flow of trade by providing safeguards against piracy.62 These international
protections will be discussed below for inventions and discoveries deriving from
marine genetic resources, marine scientific research, and bioprospecting.
63
a) Copyrights on scholary publicalions of marine sdenlific research
and bioprospecting.
Although works must be creative to be protected, the creativity
requirement in copyright law is not very strict and admits almost any original
creation, including scientific reporting. 6' Therefore, it is entirely possible that
copyrights would protect scientific communications of information regarding
MGRs found in areas beyond national jurisdiction. Despite this protection
extending to the expression of scientific information, it is important to
remember that scientific content cannot be protected by copyright. This
fundamental notion of copyright law, often referred to as the "idea-expression
dichotomy," establishes that only the expression of an idea can be protected,
rather than the idea itself.6
59 Agreement on Trade-Related Aspects of Intellectual Property Rights, Art. 7, Apr. 15, 1994,
Marrakesh Agreement Establishing the World Trade Organization, Annex 1C, 1869 U.N.T.S. 299,
33 I.L.M. 1125, 1197 (1994) [hereinafter 'TRIPs"].
60 K. Russell LaMotte, Access to Benefit Sharing: Risks and Opportunities in the Regulation of Bioprospecingfcr
Genetic Resources, ALI-ABA Course of Study Materials in International Environmental Law, at 3
(2006) [hereinafter "LaMotte"].
61 TRIPs, supra note 59, Preamble.
62 Ruth Gana Okediji, Cqopyright and Public Welfare in Global Perspective, 7 IND. J. GLOBAL LEGAL STUD.
117,119-20 (1999).
63 It should also be noted here that while the Patent Cooperation Treaty, Jun. 19, 1970, 1160
U.N.T.S. 231, [hereinafter "PM'] addresses the issue of patents in the international sphere, this
treaty is a patent filing system, not a patent granting system. See Conference of the Parties of the
Convention on Biological Diversity (8th mtg.), Mar. 20-31, 2006, Interrelation of Access to
Genetic Resources and Disclosure Requirements in Applications for Intellectual Property Rights:
Report of the World Intellectual Property Organization 194, UNEP/CBD/COP/8/INF/7
(Jan. 16, 2006) [hereinafter "UNEP/CBD/COP/8/INF/7'1.
64 SAM RICKETSON & JANE C. GINSBURG, INTERNATIONAL COPYRIGHT AND NEIGHBORING RIGIHITS:
TI-E BERNE CONVENTION AND BEYOND 406 (2005) (noting that scientific articles are subject to
copyright if they contain "written description of an experiment, process, device or the like'). See
alsoid. at 413 (including "technical and scientific"writings as being subject to copyright); MERGES,
supra note 52, at 372 (stating that only a modicum of originality was required).
65 MERGES, spra note 52, at 395-96.
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Requirements of "copyrightability" reflect the desire to foster
dissemination of knowledge. In particular, creative efforts must be materially
supported, by expressing them in writing for instance, in order to become
copyrightable subject matter. This requirement pressures creators to record their
work, thereby making it more easily disseminated. Such a requirement
additionally facilitates the preservation of works for the benefit of future
generations.
b) Patents on inventions deriving from marine genetic resources.
TRIPs establishes the types of innovation that must be granted patent
protection. Inventions in all fields of technology are patentable, whether
products or processes, provided that they are new, involve an inventive step
(nonobvious), and are capable of industrial application (useful).'
TRIPs also provides states with the possibility to exclude certain inventions
from patent protection. Some specific exceptions allow the denial of a patent
covering subject matter such as diagnostic, therapeutic, and surgical methods for
the treatment of humans or animals.67 The Agreement also provides general
exceptions to protect human, animal, or plant life or health, for reasons of
morality or to avoid serious prejudice to the environment.6"
TRIPs also specifically provides that states may choose to exclude plants
and animals other than microorganisms, as well as essentially biological
processes for the production of plants or animals (other than nonbiological and
microbiological processes).69  Protection must therefore be provided for
microorganisms, microbiological processes, and nonbiological processes.70
Genes, however, are not mentioned in the TRIPs Agreement. States may be
allowed to exclude genes from patentability, on moral grounds for instance. If
66 TRIPs, supra note 59, Art. 27(1) and accompanying note 5. As a result, three categories of subject
matter typically fall outside the scope of patentability: "The laws of nature, physical phenomena,
and abstract ideas." Diamond v. Chakrabarty, 447 U.S. 303, 309 (1980) [hereinafter
"Chakrabarty'".
67 TRIPs, supra note 59, art. 27(3)(a).
68 Id., art. 27(2). Interestingly, this permitted exception is in line with the CBD provisions, requiring
the dismissal of international obligations that would cause serious damage or threat to biological
diversity. See CBD, supra note 31, art. 22.
69 TRIPs, supra note 59, art. 27(3).
70 Id., art. 27(3). For discussion on the meaning of these categories of inventions, see GRAHAM
DUTFIELD, et al., ExPi.ORING THE FI.EXIBILITIES OF TRIPS TO PROMOTE BIOTECHNOLOGY
CAPACITY BUILIDING AND APPROPRIATE TEECiNOI.OGY TRANSFER, FINAl REPORT IPDEV WORK
PACKAGE 7 (Nov. 2006) [hereinafter "IPDEV Report'l.
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this exception is not accepted, an exception might be carved out for the use of
genes as an essentially biological process."'
Genetic inventions and biotechnological patents, defined as those related
to nucleotide DNA or RNA sequences, are available and increasingly common
in many jurisdictions, including several OECD countries.7 2 In the 1980 Diamond
v. Chakrabarty case, the United States Supreme Court decided an important legal
landmark attracting global attention. In Chakrabarty, inventions involving man-
made biological materials and some life forms were held patentable; the court
famously stating that patentable subject matter includes "anything under the sun
that is made by man. ''73
The Supreme Court of Canada tempered this view in 2002, when it denied
a patent on the Harvard oncomouse, a manmade, genetically modified mouse
with increased susceptibility to developing cancer, making them useful for
animal carcinogenic studies.7 4 The Court drew a distinction between lower life
forms and higher life forms, such as mice, countering the generous practices of
the United States Patent Office and the European Patent Office, which granted
a patent on the oncomouse.75
As stated above, Chakrabaroy established the practice of patenting
nonnaturally occurring living organisms. On the other hand, while products of
nature are excluded from patentability, naturally occurring substances that are
isolated from their surroundings may also be patented.76 Indeed, the isolation of
such substances may be sufficient to render the product inventive, especially if
significant inventive skill was required to obtain the product, rather than mere
action of a technician. Evidently, the product must also pass the other patenting
requirements such as utility. Thus, the isolated product must manifest a
particular use, which arises from the purification or isolation. 77
Any application for patent for an invention derived from MGRs must also
meet the disclosure requirements of patent law, such as disclosure of known
prior art, identity of inventor, and best mode of carrying out the invention.
71 PDEV Report, supra note 70, at 63 (describing that while a gene may not be excluded as a
biological process, the use made of genes could be excluded from patent since a gene is what
governs most biological processes).
72 DAVID KENNETH LEARY, INTERNATIONAl. LAW AND THE GENETIC RESOURCES OF THE DEEP
SEA 7.5.2 (Publications on Ocean Development 2007) [hereinafter "LEARY'].
73 Chakrabarty, supra note 66, at 309.
74 Harvard College v. Canada (Commissioner of Patents), [2002] 4 S.C.R. 45 (Can.).
75 Id. at 47.
76 See SCHECHTER, supra note 51, § 14.3.1 (significant artificial changes to a product of nature may
render it patentable).
77 Seefor example, Parke-Davis & Co. v. H.K. Mulford & Co., 189 F.95 (S.D.N.Y. 1911), aff'd 196
F.496 (2d Cir. 1912).
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These requirements range from substantive, which can cause the invalidation of
a patent, to formality requirements (such as the names and addresses of
inventors), which can be rectified unless fraud is proven.78 Typically, fraud upon
the patent office (fraudulently hiding known information) is punishable by loss
of patent rights.
Indeed, the patent system was engineered to promote transparency and full
disclosure: "[T]he concept of laying open for public inspection is the source of
the English word 'patent."' 79 As a result, the invention may be effectively and
freely practiced by the public at the expiration of patent protection.
TRIPs incorporates this requirement and states that patent applications
shall "disclose the invention in a manner sufficiently clear and complete for the
invention to be carried out by a person skilled in the art."' Hence, the written
description of a patent must be enabling, meaning that it must contain a
description of the invention in sufficient detail to permit a person skilled in the
art to repeat the invention.
However, enabling descriptions are particularly elusive in the field of
biotechnology, since microorganisms and biological material are difficult to
describe in written form. As a result, patent applicants may satisfy disclosure
requirements by depositing a sample of the invention, according to the Budapest
Treaty on the International Recognition of the Deposit of Microorganisms for
the Purposes of Patent Procedure. 8 This deposit ensures that the patented
material will be accessible to persons other than the inventor, for experimental
use purposes during the patent lifetime as well as any use after the expiration of
patent protection.
III. THE PRESENT AND ITS CONTROVERSIES
Many international issues have yet to be resolved with regard to marine
genetic resources found in areas beyond national jurisdiction. These issues relate
to both the law of the sea and IP law.
78 UNEP/CBD/COP/8/INF/7, supra note 63, 179. See Draft Treaty Supplementing the Paris
Convention for the Protection of Industrial Property as Far as Patents Are Concerned (Patent
Law Treaty), art. 10(1), WIPO Doc. PLT/DC/3 (Dec. 21, 1990) [hereinafter "PLT'] (providing
that failure to meet substantive requirements renders a patent invalid, whereas failure to meet
formal requirements may be rectified, unless fraudulent).
79 UNEP/CBD/COP/8/INF/7, spra note 63, 95.
80 TRIPs, supra note 59, art. 29(1).
81 Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the
Purposes of Patent Procedure, Apr. 28, 1977, 32 U.S.T. 1241, 1861 U.N.T.S. 361 [hereinafter
"Budapest Treaty'].
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A. Some Questions of Relevance in the Law of the Sea Sector
As previously mentioned, UNCLOS did not address the Area's biological
resources and focused on its mineral resources.82 Thus, the international legal
regime that applies to these resources is unclear and consists of a patchwork of
legal instruments, including UNCLOS, the CBD, and intellectual property rights
agreements, none of which directly address MGRs in areas beyond national
juisdiction nor provide a comprehensive mechanism governing activities such
as bioprospecting in these areas.83
Nevertheless, as the "constitution of the oceans," UNCLOS is generally
accepted to be the starting point for handling legal questions regarding MGRs
located beyond areas of national jurisdiction. In particular, UNCLOS has been
the basis for the highly contested legal regime governing these resources, which
could either be found analogous to seabed mineral resources and part of the
common heritage of mankind, or instead could fall under the resources of the
high seas, generally free to be collected and sampled by all.'
The outcome of this categorization would have very senious consequences
on states. Indeed, should MGRs fall under the common heritage of mankind as
many developing states maintain, equitable benefit sharing would apply and,
consequently, products derived from these resources should also be the
common heritage of mankind. On the other hand, should MGRs be considered
part of the high seas, the obligation of sharing benefits might be eliminated,
82 Glowka, supra note 32, at 56.
83 LaMotte, supra note 60 (noting that a number of instruments exist that may be relevant to
bioprospecting activities, including international mechanisms to protect the marine environment
and measures to establish marine protected areas).
84 A/65/68, supra note 9,% 71-72, which explains the divergent views expressed on the legal regime
of MGRs beyond areas of national jurisdiction under UNCLOS:
Several delegations observed that, according to General Assembly resolution
2749 (XXV) and Part XI of the Convention, which they noted was part of
customary international law, the seabed and ocean floor and the subsoil
thereof beyond the limits of national jurisdiction (the "Area'), as well as its
resources, were the common heritage of mankind. They emphasized that the
common heritage of mankind, including the fair and equitable sharing of
benefits, applied to the biological resources of the Area.... Other delegations
stressed that Part XI only addressed mineral resources, and expressed the view
that marine genetic resources beyond areas of national jurisdiction were
regulated by the high seas regime in Part VII of the Convention.
See also A/60/63/Add.1, supra note 12, 201; United Nations General Assembly (59th Sess.),
Report on the work of the United Nations Open-ended Informal Consultative Process on Oceans
and the Law of the Sea at its fifth meeting 90, U.N. Doc. A/59/122 Gul. 1, 2004); U.N.
Secretary General, Addendum Report of the Secretary General on Oceans and the Law of the Sea
to the General Assembly (62nd Sess.) 276, U.N. Doc. A/62/66/Add.2 (Sept. 10, 2007).
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depending on the interpretation of marine bioprospecting.81 Indeed, if
bioprospecting is considered to be maine scientific research, the products of
bioprospecting would fall under UNCLOS Part XII, which contains
information dissemination obligations and specifies that such research cannot
constitute the legal basis for any claim to any part of the marine environment or
its resources.86 If, however, bioprospecting is found to be distinct from marine
scientific research, then products of marine bioprospecting in the high seas
would be free for all to capture. 87
The interpretation of bioprospecting is difficult. To be sure, while
bioprospecting includes a component of pure research, it is unclear whether the
commercial objective of bioprospecting makes this activity tantamount to
exploitation, especially considering that the outcome of bioprospecting is often
highly uncertain.
Should bioprospecting be considered marine scientific research, it would
appear that granting patents protecting inventions derived from such activities
would be contrary to UNCLOS provisions regarding scientific research that
prohibit the use of such activities as the legal basis for any claim to any part of
the marine environment or its resources.88 Furthermore, many states are
concerned about the use of IP rights as a means to privatize genetic resources
without sharing benefits.89
B. Intellectual Property-Misco nc eptions and Realities
To be sure, IP protection is often regarded as the granting of a monopoly,
with benefits falling solely on the right holder. However, IP is not necessarily
contrary to benefit sharing. It should be recalled that intellectual property
protection is not a dam, used to fend off users; rather it is a river, meant to
channel and direct the use of the material subject to its rule. 90
For instance, as stated above, patents and copyrights promote disclosure,
which is in line with UNCLOS objectives of dissemination of knowledge and
85 UNCLOS does not define, nor even mention, the term bioprospecting. A/60/63/Add.1, supra
note 12, 1 203 (statingthat there is no internationally agreed definition for either marine scientific
research or bioprospecting).
86 UNCLOS, supra note 13, arts. 241, 244.
87 Unless Area marine genetic resources are brought together with mineral resources under the
authority and governance of the International Seabed Authority.
88 UNCLOS, supra note 13, art. 241.
89 WIPO/GRTKF/IC/7/9, supra note 33, Annex (Preliminary Note).
90 Daniel J. Gervais, Towards a New Core International Copyrzght Norm: The Reverse Three-Step Test, 9
MARQ. INTELL. PROP. L. REV. 1, 7 (2005).
W/inter 2014
Heafy
Chicago Journal of International Law
access to information.9 On this topic, some important principles can be drawn
from TRIPs, which states that protection and enforcement of intellectual
property rights should contribute to the advancement and transfer of
technology.92 For instance, protection of patent rights reassures inventors that
they will not lose control of their inventions, thereby facilitating collaborations
that promote technology transfer and capacity building. Collaborations also
maximize the scientific returns from resources available and minimize the
impact of research on the environment.
This was foreseen in drafting the CBD, which recognizes that TP can be
supportive of, and not run counter to, the objectives of the CBD. 93 Interestingly,
the CBD Secretariat's review of the impact of IPRs on the CBD's objectives
stated that "[i]dentifying and allocating IPR will be an important part of
controlling access to genetic resources and facilitating the fair and equitable
sharing of benefits."94
Further to this point, it should also be noted that the application for a
patent should not be considered to be a claim to part of the marine environment
or its resources, in a sense contrary to Article 241 of UNCLOS. Indeed, a patent
is only granted in respect of new and useful inventions; it may not be granted in
respect of naturally occurring elements-for in that event the inventor did not
invent, he merely discovered. Therefore, when a patent is granted in respect of an
invention, it does not grant any right to the patent holder in respect of the
natural resources on which that invention may be based, nor does it grant any
kind of ownership right to the patent holder. A patent grants the right to
exclusive use of the invention covered by the patent, for the duration of the patent
term. 9'
In light of these realizations, there is a common need to understand the full
range of options offered by IP that promote global interests and benefit sharing.
Several of these options will be explored in the following section.
Before discussing the use of IP to promote access and benefit sharing, it
should be noted that states are permitted by international law to create
limitations and exceptions to IP rights. These domestic limitations and
91 See UNCLOS, supra note 13, arts. 143(3)(c), 244.
92 TRIPs, supra note 59, art. 7.
93 See Charles Lawson& Susan Downing, It's Patently Absurd BenefitSharing GeneticResources from the
Sea Under UNCLOS, the CBD and TRIPs, 5 J. INT'L W1LDLnri L. & POL'Y 211, 223 (2002).
94 See Conference of the Parties of the Convention on Biological Diversity (3 rd mtg.), The Impact of
Intellectual Propery Rights Systems on the Conservation and Sustainable Use of Biological Diversio and on the
Equitable Sharing of Benefits from Its Use 9, UNEP/CBD/CGP/3/22 (Sept. 22, 1996).
95 TRIPs, supra note 59, arts. 27, 28, 33.
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exceptions are valid, subjected to the validity test provided in TRIPs. 96 As seen
above, TRIPs specifically allows states to deny certain types of patents, such as
patents on therapeutic methods for the treatment of humans for instance, and
also enables states to make exceptions to protect human life or health and for
reasons of morality.
While national limitations and exceptions to IP rights must comply with
international law, international limitations and exceptions can form a suigeneris
system of IP protection, provided that it is supported by the international
community.
IV. THE ENLIGHTENED FUTURE: MOVING AWAY FROM
THE CONTROVERSIES
International law leaves many questions unanswered: Are marine genetic
resources found in areas beyond national jurisdiction part of the common
heritage of mankind? If they are not, do they fall under the freedom of the high
seas of UNCLOS Part VII? Is marine bioprospecting in the Area simply marine
scientific research, which must be conducted for the benefit of all mankind?
Due to the highly controversial nature of these questions, it appears that
engaging in these debates will only prolong the stalemate.97 It seems more
productive to move away from the controversy and proceed towards a solution
by using the legal means that are already available, by tailoring a special IP
regime to handle access to information on marine genetic resources found
beyond national jurisdiction and benefits that derive from them.
Firstly, it is important to note that entirely barring protection for
inventions deriving from MGRs from areas beyond national jurisdiction is
difficult, as patents constitute a key incentive behind research and product
development in relation to these resources.98 Patent protection rewards the
inventor for the effort, cost, and investment in developing the product; without
such protection, it is unlikely that product development would occur to the
96 Id., art. 13 (copyrights: "Members shall confine limitations or exceptions to exclusive rights to
certain special cases which do not conflict with a normal exploitation of the work and do not
unreasonably prejudice the legitimate interests of the right holder"), art. 30 (Patents: "Members
may provide limited exceptions to the exclusive rights conferred by a patent, provided that such
exceptions do not unreasonably conflict with a normal exploitation of the patent and do not
unreasonably prejudice the legitimate interests of the patent owner, taking account of the
legitimate interests of third parties").
97 LEARY, supra note 72, 7.8.
98 Id., 7.7. 1.
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extent it does today.99 Thus, it is important to maintain the incentives created by
the patent system while balancing the global interests in benefit sharing.
In a recent article, Angelica Bonfanti and Seline Trevisanut suggest that the
exploitation of MGRs should be carried out according to two fundamental
principles: prior and informed consent to access MGRs, and the fair and
equitable sharing of benefits from these resources." Although the first principle
finds little or no application in areas beyond national jurisdiction, fair and
equitable sharing of benefits is a notion that is central to the issue and is
supported by the majority of states.101
Benefit sharing lessons can be extracted from other international
instruments, such as the International Treaty on Plant Genetic Resources for
Food and Agriculture (FAO Treaty) and the CBD. The former treaty creates an
open, public space of research commons by calling upon states to share their
genetic resources for food and agriculture with the rest of the world in exchange
for free access to resources from other parts of the world. To this end, the FAO
Treaty establishes the Multilateral System of Access and Benefit Sharing (MELS).
Recipients of MLfS materials who commercialize a product that is a plant genetic
resource for food and agriculture incorporating material accessed through the
MLS pay to a trust account a share of the benefits arising from
commercialization. 102 These funds are intended to benefit mostly farmers who
conserve and use plant genetic resources for food and agriculture in a
sustainable manner. 3 Nonmonetary benefits are also emphasized by the FAO
Treaty, including information exchange, access to and transfer of technology,
and capacity building."° The CBD, and the Bonn Guidelines that accompany it,
also provide for sharing of monetary and nonmonetary benefits.
99 A/60/63/Add.1, supra note 12, at 28 (noting that "due to the high costs involved, patenting is
presently the main avenue for securing economic benefit as a return for investment').
100 Angelica Bonfanti & Seline Trevisanut, °1RIPs on the High Seas: Intellectual Proper i Raghts on Marine
Genetic Resources, 37 BROOK.J. INT'L L. 187, 190 (2011) [hereinafter "Bonfanti & Trevisanut'".
101 See Director General of the World Trade Organization, Issues Related to the Extension of the Protection
of Geographical Indications Provided for in Article 23 of the TRIPS Agreement to Products other than Wines
and Spirits and those Related to the Relationship between the 7lRIPSAgreement and the Convention on Biological
Diversiy, TN/C/W/50, 5 (June 9,2008); Report of the WTO Director- General on Issues Related
to the Extension of the Protection of Geographicallndicions Providedfor inArticle 23 of the TRIPS Agreement
to Products other than Wines and Spirits and those Related to the Relationship between the TRIPS Agreement
and the Convention on Biological Diversiy, TN/C/W/61, at 18 (April 21, 2011) [hereinafter "2011
report of the WTO Director-General'".
102 International Treaty on Plant Genetic Resources for Food and Agriculture, art. 13(2)(d)(ii),
available at ftp://ftp.fao.org/docrep/fao/011/i051Oe/i0510e.pdf (last visited Nov. 5, 2010).
103 Id., art. 13(3).
104 Id., art. 13(2).
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However, many aspects of these ABS systems cannot be easily transferred
to MGRs beyond national jurisdiction, since the sovereignty of these resources is
not yet legally established. For instance, the FAO Treaty is based on mutual
recognition of the Contracting Parties' sovereign rights over their own plant
genetic resources, but they agree to provide access to others for food and
agriculture.105 Similarly, the Bonn Guidelines suggest collaborations with the
provider country of the genetic resources, 1 which are impossible for resources
in areas beyond national jurisdiction given that there is no "provider country."
As previously mentioned, 1P protection can work hand in hand with
benefit sharing mechanisms and with the interests of many states who both wish
for the expansion of scientific knowledge and the protection of 1P as well as the
short and long term benefits to all mankind from marine genetic resources from
areas beyond national jurisdiction.07
In order to harness the IP protections system in pursuit of global interests
with respect to marine genetic resources from areas beyond national jurisdiction,
it would first be helpful to identify which inventions and publications derive
from bioprospecting beyond areas of national jurisdiction. To this end, several
propositions and approaches have included the insertion of a disclosure of
origin requirement. 1 0
8
A. Declaring the Source: Increased Disclosure Requirements
The proposal requiring the declaration of source for MGRs has been
supported by the document prepared in part by the United Nations University:
An Update on Marine Genetic Resources: Sdenlific Research, Commerdal Uses and aDatabase on Marine Bioprospecting.10 9
In the case of patents, the requirement could be inserted either as a
substantial requirement or mere formal element of disclosure into national law,
or could be an amendment to one of a number of international instruments,
such as the Budapest Treaty on the International Recognition of the Deposit of
105 Id., art. 10(1).
106 See,for example, Bonn Guidelines, supra note 32, art. 26(d) and Appendix Ii art. 2(b).
107 United Nations General Assembly (62nd Sess.), Report on the work of the United Nations Open-ended
Informal Consultative Process on Oceans and the Law of the Sea at its eighth meeting 67-81, U.N. Doc.
A/62/169 (Jul. 30, 2007).
108 See Bonfanti & Trevisanut, supra note 100, at 220-23; Martin A. Girsberger, Transparency Measures
under Patent Law regarding Genetic Resources and Traditional Knowledge: Disclosure of Source and Evidence of
Prior Informed Consent and Benefit-Sharing, 7 J. WORLD INTELI.. PROP. 451 (2004).
109 An Update on MGRs, supra note 41.
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Microorganisms for the Purposes of Patent Procedure,"' the Patent
Cooperation Treaty, or TRIPs. In fact, several 'WTO members, including the
European Communities, Switzerland, and many developing countries such as
Brazil have agreed that TRIPs should be amended to include a mandatory
requirement for the disclosure of the source of genetic resources in patent
applications. "'
If a source disclosure requirement implemented in national law is
considered to be a mere formality, such a requirement would likely be consistent
with TRIPs, which allows states to require compliance with reasonable
procedures and formalities as a condition of the acquisition of maintenance of
IP rights. " 2 Even if the disclosure of source would be made a substantial
requirement of protection, it may remain consistent with TRIPs provided that
the implementation of such a requirement is necessary to manage obligations
under international treaties such as UNCLOS and the CBD.1
3
Further, such a requirement does not appear to be inconsistent with the
Patent Cooperation Treaty (PCT) or the Patent Law Treaty (PET)."4 For
instance, the PCT is not intended to restrict the freedom of states to prescribe
substantive conditions of patentability. National law may require that the
applicant furnish evidence in respect to any substantive condition of
patentability such as novelty, utility, inventiveness, or disclosure."' Similarly, the
PCT provides that national law may require patent applicants to furnish any
document relating to the applicant's entitlement to apply or be granted a
patent."
6
Furthermore, given that the declaration of source could facilitate the
practice of an invention (an important element of fully enabling disclosures),
such a requirement may even be derived from the obligation to disclose the
110 While the Budapest Treaty does not currently require disclosure of source, the Assembly of
Contracting parties is allowed to amend its regulations by a majority vote of two-thirds. Budapest
Treaty, supra note 81, art. 12(3)-(4).
"' WTO Trade Negotiations Comm. (Doha Round), Draft Decision to Enhance Mutual Supportiveness
Between the TRIPS Agreement and the Convention on Biological Diversiy, TN/C/ W/59 (April 19, 2011).
See also WTO Trade Negotiations Comm. (Doha Round), Draft Modalities for TRIPs Related Issues,
TN/C/W/52, Item 4 (July 19, 2008).
112 TRIPs, supra note 59, art. 62.
"3 Geertrui Van Overwalle, Protecting and Sharing Biodiversity and Traditional Knowledge: Holder and User
Tools, 53 EcOLOGicAL ECON. 585, 599 (2005).
114 See UNEP/CBD/COP/8/INF/7, supra note 63, 196.
115 PCT, spra note 63, art. 27. See also MERGES, supra note 52, at 124 (describing patentability
requirements in US).
116 PCT, spra note 63, Rule 51 bis.
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invention sufficiently for it to be carried out by a person skilled in the art and
where appropriate, to disclose the best mode known by the inventor.
In the case of genetic resources located within national jurisdiction, the
advantage of declaring their source would be to enable states to monitor
whether samples have been obtained in accordance with the CBD framework
that requires that ABS arrangements have been made. The Berne Declaration
reaffirms this advantage by noting that source disclosure requirements are "one
important tool to make sure that no patents are granted for inventions which are
based on genetic resources ... which have been accessed in contradiction with
CBD rules." '117 If the genetic resources are located in areas beyond national
jurisdiction, a special IP regime, which will be described below, could be
triggered.
Should source disclosures become a requirement, some wrinkles must be
ironed out. Firstly, the consequences for lack of disclosure must be established.
In other words, it must be decided whether the disclosure of source is a
substantive requirement, or a mere formality. Typically, formalities can be
rectified once good faith error is established, whereas failures to comply with
substantial disclosure requirements void the patent entirely whether fraudulent
or not."8 These general principles, however, can be modified. For instance, loss
of patent rights for failure to comply could be triggered for inventions deriving
from MGRs located in areas beyond national jurisdiction only in cases of
fraud."9 Another option is to trigger the loss of patent rights for lack of
compliance only in cases where the inventions would be subject to ABS
regulations, or if it is shown that disclosure of origin would have likely denied
the application for reasons of ordrepublic, lack of novelty, or otherwise.
On the other hand, a softer disclosure requirement could cause mere
unenforceability in infringement cases rather than invalidity of the patent rights.
This would therefore constitute a defense for infringement rather than a claim of
invalidity. Softer requirements, which have less important consequences for
noncompliance, are more similar to the absence of requirements. In this sense,
decreasing the severity of noncompliance sanctions also enhances the
requirement's consistency with freedom of high seas principles.
Before moving forward with this requirement, it must be established
whether noncompliance can be challenged by any party or only an infringing
117 Comments by the Berne Convention on WIPO/IP/GR/05/1 in UNEP/CBD/COP/8/INF/7,
sapra note 63, 112.
118 Note that according to PLT, supra note 78, art. 10(2), a patentee must be given the opportunity to
make observations on the intended revocation of a patent, and to make amendments and
corrections where permitted under the law, within a reasonable time limit.
119 See PLT, supra note 78, art. 10.
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party. On this topic, it should be noted that in all cases, the burden of proof
should lie with the party alleging noncompliance. This follows the generally
accepted presumption that patents are valid and ensures more stability in the
patent system.
Secondly, it is necessary to determine the kind of link that triggers the
disclosure of source requirement. 20 TRIPs and the PCT would suggest that the
requirement would be triggered in cases when the source of the genetic material
or the access to it is necessary to carry out or replicate the invention as
claimed. 2' This requirement might also be triggered if access to the material is
necessary to implement the best mode disclosed in the application or to practice
another example given in description of the patent. Other options would trigger
this requirement if the physical deposit of a sample were required for
enablement, when material used directly led to the invention and is essential to
deriving the invention, or when material used led to the invention but was only
incidental to the attainment of the invention. 2
Interestingly, the European Community welcomes disclosure of source,
123
stating that, "if an invention is based on biological material of plant or animal
origin or it uses such material, the patent application should, where appropriate,
include information on the geographical origin of such material, if known."'
24
The language ("where appropriate," "if known ' ) suggests, however, that this is a
soft requirement and that failure to comply is without prejudice to the
processing of patent applications or the validity of rights granted. In Norway,
the requirement appears to be stricter: "If an invention concerns or uses
biological material, the patent application shall include information on the
country from which the inventor collected or received the material."' 2 Despite
the support for source disclosure, the U.S. maintains that such a disclosure
requirement would create uncertainties in the patent system that would
discourage research and development and the corresponding publication of
inventions. In light of this statement, it should be kept in mind that full
120 See UNEP/CBD/COP/8/INF/7, supra note 63, 1 85.
121 TRIPs, supra note 59, art. 29; PCT, supra note 63, art. 5.
122 EC proposal, in UNEP/CBD/COP/8/INF/7, supra note 63, 122.
123 Communication by the European Community and its Member States to the TRIPs Council on
the Review of Article 27.3(b) of the TRIPs Agreement, and the Relationship between the TRIPs
Agreement and the Convention on Biological Diversity and the Protection of Traditional
Knowledge and Folklore, Directorate General for Trade (Sept. 12, 2002).
124 Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the Legal
Protection of Biotechnological Inventions, Preamble, Recital 27, 1998 O.J. (L 213/13).
125 Patents Act, May 7, 2004, § 8(b).
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disclosure is germane to the patent system and has always played a role in
ensuring that patents do not reward inequitable behavior.
The disclosure of source would enable the implementation of a special IP
regime, applying to Ip deriving from bioprospecting in areas beyond national
jurisdiction. However, as noted by the WTO Director-General in 2011, many
states continue to differ on whether the formulation and application of a
disclosure mechanism relating to genetic resources in TRIPs would be useful
and effective in ensuring that the patent system promotes CBD objectives, or
whether other mechanisms should be preferred. 126 The other mechanisms
proposed by states include (1) disclosure through the World Intellectual
Property Organization by amending the regulations of the PCT (and, by
reference, the PLT) so that domestic laws may ask inventors to disclose the
source of genetic resources when they apply for patents. Failure to meet the
requirement could hold up a patent being granted or, when done with fraudulent
intent, could entail a granted patent being invalidated; (2) disclosure outside
patent law, such that all patent applicants would be required to disclose the
source or origin of genetic material, with legal consequences of not meeting this
requirement which lie outside the scope of patent law; and (3) use of national
legislation, including contracts rather than a disclosure obligation, which could
include commitments on disclosing any commercial application of genetic
resources.
B. New Possibilities for a Special IP Regime
The disclosure of the source would enable the establishment of a suigeneris
protection regime for IP deriving from MGRs located in areas beyond national
jurisdiction. The list that follows is by no means exhaustive, but does reflect
many current suggestions regarding the possible options.
Whether the options are adopted through international implementation
agreements or an ad hoc convention, these would be supported by the Nagoya
Protocol, which requires that Contracting States consider "the need for and
modalities of a global multilateral benefit sharing mechanism to address the fair
and equitable sharing of benefits derived from the utilization of genetic
resources" that occur, inter alia in situations for which it is not possible to grant
or obtain prior informed consent,"2 such as in the case of resources from areas
beyond national jurisdiction.128
126 2011 Report of the WTO Director-General, sufpra note 101, 27.
127 Nagoya Protocol, supra note 34, art. 10.
128 Bonfanti & Trevisanut, supra note 100, at 229.
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1. Commons Repository.
First and foremost, the disclosure of source would allow the creation of a
Commons Repository, where all IP (patents and scholarly publications) deriving
from MGRs from areas beyond national jurisdiction would be compiled. In
support of the common heritage of mankind approach, the Repository would
effectively become a central archive and compendium, recording all
advancements deriving from these resources, leading to increased accessibility to
information. While providing access to information, the Repository would,
however, fully preserve IP protection, therefore perhaps tending more towards
the principles of the high seas. Tending even further towards the freedom of the
high seas approach, deposit of protected IP could be made mandatory only after
the lapse of a certain length of time (for instance after two, six, or twelve
months).
Several advantages would stem from the heightened "searchability" of
information, including better informed policy debates. 29 Such a record would
also permit better prior art searches, enabling the defensive protection of MGRs
by preventing the grant of patents over resources that are not novel or
obvious."3°
2. Commons Trust Fund: patent royalties.
The Commons Trust Fund ("Fund") is frequently mentioned as a viable
option for ABS regarding MGRs from areas beyond national jurisdiction.' 3 The
Fund would be similar to the FAO Treaty, whereby developers of a commercial
product using designated resources (MLS materials, or MGRs from areas
beyond national jurisdiction in this case) are required to pay royalties to the
Fund. The Fund would be used to protect these resources, thereby providing
benefits to all mankind. In other words, the use of commons resources is made
dependent on some of the benefits arising from their use flowing back into their
protection.
This Fund would provide the long awaited link between international IP
protections and the conservation of biodiversity. Indeed, the need for funding
biodiversity conservation and sustainable development is notably recognized in
the CBD, and has been for some time already (at least since 1987, by the
Bruntland Commission). 32
129 A/60/63/Add.1, supra note 12, at 74.
130 WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional
Knowledge and Folklore, Genetic Resources: List of Options, Annex 1, 5-6,
WIPO/GRTKF/IC/1 1/8(a), (June 3, 2007).
131 A/60/63/Add.1, spra note 12, at 28.
132 An Update on MGRs, supra note 41.
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Interestingly, India has already established a similar system whereby all
inventors must obtain the consent of the National Biodiversity Authority before
applying for patent rights based on an Indian biological resource, and grants the
Authority the power to impose the sharing of financial benefits arising out of the
commercial utilization of such rights.133
In the spectrum of options between the common heritage of mankind and
the freedom of the high seas approaches, the Commons Trust Fund falls closer
to the realm of the common heritage of mankind. However, the royalty rate can
be varied resulting in the displacement of the option towards the freedom of the
high seas principles in the case of lower royalty rates. Indeed, one can imagine
that if these rates are lowered to an infinitesimal amount, the existence of the
patentee's obligation to pay royalties will be negligible, thereby harmonizing the
option with freedom of high seas principles.
This work is not geared towards finance and economy, and will therefore
not determine the exact value that should be given to a royalty rate. However, a
suitable benchmark figure might be similar to the amounts paid under ABS
arrangements within national jurisdictions. In the determination of the royalty
rate, it should be kept in mind that research and development costs might be
higher for deep-sea research, thus suggesting that royalty rates be lower for such
efforts. On this topic, it is interesting to consider that a royalty rate of 1. 1
percent of product salesM was agreed to by the FAO Treaty's govering body
and is reflected in the MLS standard material transfer agreement (Annex II).
The management of the Commons Trust Fund could naturally be
entrusted to the International Seabed Authority (ISA), who already has the
mandate to distribute wealth generated from the exploitation of the mineral
resources of the Area pursuant to Article 82 of UNCLOS. Having said that, it is
unclear whether the ISA would be enabled to face the difficulties of managing
such a system.13 Indeed, the ISA has not yet developed rules or procedures for
equitable sharing of benefits and its ability to distribute wealth is still unproven.
On the other hand, the Global Environmental Facility (GEF) already has
experience in providing funding to assist developing countries in meeting the
objectives of international environmental conventions and serves as the financial
mechanism for four conventions: the CBD, the UNFCCC, the United Nations
Convention to Combat Desertification, and the Stockholm Convention on
133 Philippe Cullet & Jawahar Raja, Intellectual Properoy Rights and Biodiversiy Management- The Case of
India, 4 Gi.OBAL ENVTL. POE. 97, 103 (2004).
134 As deep-sea bioprospecting is a high-risk enterprise, royalties should be based on actual sales of
product to ensure that only profitable patents are required to contribute to the fund. See LEARY,
spra note 72, 7.7.2.
135 See,for example, Bonfanti & Trevisanut, supra note 100, at 217.
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Persistent Organic Pollutants. The GEF handles a range of projects that address
global issues related to sustainable development and the environment, like
biodiversity, climate change, international waters, land degradation, and ozone
depletion.
The GEF may be well placed to act as the financial mechanism for
managing the benefit sharing of proceeds deriving from patents based on MGRs
from areas beyond national jurisdiction.136
As previously mentioned, the Fund could provide funding for research on
the conservation and sustainable development of these resources. In assessing
funding applications, consideration could be given to efforts on behalf of the
applicant to transfer technology, provide capacity building, and contribute to the
local economy of developing states. Along these lines, those applicants having
voluntarily published to the Repository could also be rewarded.
Furthermore, research projects funded by the Fund could be granted free
access to copyrighted material and use of patented inventions pushing this
option even closer to the common heritage of mankind approach.
3. Experimental and customary use exceptions.
The experimental use exception is broadly accepted by many states and
allows the use of protected material for noncommercial research. This
exemption is generally used as a defense to infringement claims.
The definition of noncommercial research is central to the application of
this exemption. Generally speaking, research with the goal of adding knowledge
to the public domain, without restrictions or proprietary interests, is
noncommercial in nature. In practice, it occasionally becomes difficult to
distinguish between experimental research and commercial enterprises.
Participants in the Bonn workshop compiled a list of indicators that separate
noncommercial from commercial research, such as restrictions on dissemination
of research results, restrictions on access to reference specimens and patent
applications.'37
Another post facto defense is the customary use (or prior use) exemption,
which maintains the right of communities to use inventions that are already
known by them.
136 This option could be pursued under the auspices of the GEF's International Waters or
Biodiversity Projects. Global Environmental Facility Focal Areas, at http://www.thegef.org/gef/
InternationalWaters and http://www.thegef.org/gef/biodiversity. See LEARY, supra note 72,
17.7.3.
137 David E. Schindel, Christoph L. Hauser & Scott E. Miller, Preserving InternationalAccess to Genetic
ResourcesforNon-commerdalBiodiverjii Research, submitted for publication, in review, 2009, available
online at http://www.cbd.int/abs/doc/cbol-dfg-bonn-abs-article-en.pdf (last visited May 2,
2013).
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A stricter option for experimental use, distancing this exception from the
common heritage of mankind approach, admits the experimental use exception
only for experimental projects funded by the Commons Trust, as mentioned
above.
Another option, which renders the exemptions even more restrictive,
would require a prior agreement between the user and the right holder. Such an
option leaves the experimental and customary use exceptions tantamount to a
compulsory license because of the individualized contractual relationship
between the parties. Note, however, that unlike conventional compulsory
licenses, it provides no compensation to the right holder.
4. Compulsory and commons licenses.
Compulsory licenses force IP right holders to grant permission to others to
use their protected IP. In exchange for this permission, licensors are
compensated as provided by law. Compulsory licenses may be ornamented by
various terms that tend to lessen the impact of compulsory licenses on IP right
holders. For instance, grant-back or assign-back clauses make improvements
made by the licensee freely available to the licensor. Minimum performance
clauses set specific performance targets in order to ensure sufficient payments to
the licensor.
Some license terms tend away from the full protection of IP and thus, the
freedom of the high seas, such as provisions requiring that the licensor assist the
licensee in effective exploitation of the licensed IP by furnishing technical
support, training and advice. Cross-licenses, on the other hand, theoretically
benefit licensors and licensees equally as they allow both parties to use each
other's M
In the suigeneris IP regime, tiered pricing of compulsory licenses could be
established for developing states or projects funded by the Commons Trust
Fund, for example. Pushing towards the common heritage of mankind
approach, a fraction of proceeds generated by compulsory licenses on
copyrighted and patented material could be paid to the Fund.
Commons licensing is also gaining momentum and acceptance as a
"mechanism for improving access, documenting ownership, and giving
attribution to providers while prohibiting commercial use."'38 The IP right
holder grants these licenses to a licensee to freely use the protected material. As
a result, creative and science commons licenses do not generate income for the
licensor, contrary to compulsory licenses (which do generate income, but can be
used for commercial exploitation). Hence, such licenses resemble the
experimental use exceptions. Licenses can be individually tailored as the parties
138 Id. at 5.
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see fit and are useful when the relationship between licensor and licensee
requires particular arrangements.
5. Shorter time window of exclusivity and technology transfer
expiration of protection.
Although IP protection should continue to be granted, the duration of
exclusivity could be shortened for TP derived from MGRs from areas beyond
national jurisdiction. This would allow for earlier technology transfer to the
public, which occurs at the expiration of protection.
It should be noted that TRIPs provides for minimum protection terms. 1
39
These international standards can therefore only be modified by consensus, or
be permitted under the validity tests of Articles 13 and 30.
V. CONCLUSION
Intellectual property holds at its core the public interest objective of
advancing the common store of knowledge. To pursue this aim, IP offers
limited exclusive rights to inventors and creators in order to create incentives for
the production of their work. These exclusive rights do not however preclude
access and benefit sharing. In fact, TP offers several possibilities that can be
harnessed to address the concerns of states in this field regarding MGRs found
in areas beyond national jurisdiction.
Indeed, IP enhances access by encouraging the disclosure of works. Access
can be further facilitated by the creation of a Commons Repository, special
access privileges and licenses, for instance. Additionally, the lifetime of IP
protection could be reduced, to expedite full access to the work. IP also provides
a means to share benefits that are derived from MGRs. Beyond the inherent
benefits of access to knowledge and technology, financial profits can be subject
to royalty payments to a trust fund for the benefit of all.
Nevertheless, it appears that the more feasible options are those that do
not alter the current IP system too significantly and rather use the current
features of the system to serve the interests of states and the marine
environment. Changing the lifetime of IP protection might be more difficult
than, for instance, establishing a Commons Repository.
In the short term, state governments can act by directing state
funding agencies to attach special provisions to grants given for marine scientific
research in areas beyond national jurisdiction. States could, if they chose to,
condition research grants on the deposit of all copyrighted and patented works
to a special repository. One hopes that such individual state efforts might pave
Vol 14 No. 2
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the way to worldwide participation in an effort to protect and preserve the
marine environment, promote economic growth, and foster technological
innovation. Intellectual property can, and ought to be, a valuable player in this
endeavor.
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